Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
173 hedge funds and large institutions have $1.42B invested in Silk Road Medical, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 79 increasing their positions, 52 reducing their positions, and 43 closing their positions.
52% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 52
3% less call options, than puts
Call options by funds: $8.43M | Put options by funds: $8.67M
11% less funds holding
Funds holding: 194 → 173 (-21)
17% less capital invested
Capital invested by funds: $1.71B → $1.42B (-$289M)
47% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 43
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$73.1M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$13.2M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$11.3M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$10.5M |
| 5 |
BlackRock
New York
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$31.1M |
| 2 |
DM
Deerfield Management
New York
|
-$21.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$19.2M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$19.1M |
| 5 |
Jennison Associates
New York
|
-$13.1M |
SILK Hedge Fund Activity: Q2 2023 in Review
173 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q2 2023, worth a combined $1.42B — down 17% from $1.71B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of SILK and 23 opened new positions — a net loss of 20 holders — while 52 trimmed existing stakes and 79 added.
The largest buyer was Wasatch Advisors, adding an estimated $73.1M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $31.1M sold.
- 173 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q2 2023, down from 194 in Q1 2023.
- Funds reported $1.42B of Silk Road Medical, Inc. Common Stock stock for Q2 2023, down 17% quarter-over-quarter.
- 23 funds opened new Silk Road Medical, Inc. Common Stock positions in Q2 2023 and 43 closed out, a net change of -20 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q2 2023 was Wasatch Advisors, an estimated $73.1M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q2 2023 was Lord, Abbett & Co, an estimated $31.1M sold.
Based on aggregated 13F filings for Q2 2023.